Late Gadolinium Enhancement CMR Predicts Adverse Cardiovascular Outcomes and Mortality in Patients With Coronary Artery Disease: Systematic Review and Meta-Analysis

Progress in Cardiovascular Diseases

Volumn 54, Issue 3, 2011, Pages 215-229

  Zemrak, Filip ^a   Petersen, Steffen E ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Coronary artery disease; Death; Late gadolinium enhancement; Major adverse cardiac event; Mortality; Predictive value

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE; GADOTERIDOL; GADOVERSETAMIDE;

ADULT; ADVERSE OUTCOME; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CONTRAST ENHANCEMENT; CORONARY ARTERY DISEASE; DIAGNOSTIC VALUE; DOSE RESPONSE; FEMALE; HEALTH HAZARD; HEART INFARCTION SIZE; HUMAN; LATE GADOLINIUM ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; CONTRAST MEDIA; CORONARY ARTERY DISEASE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 80054785323     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.07.003     Document Type: Article

References (41)

1. Kwong R., Korlakunta H. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability. Top Magn Reson Imaging 2008, 19:15.
2. Hombach V., Merkle N., Bernhardt P., et al. Prognostic significance of cardiac magnetic resonance imaging: Update 2010. Cardiol J 2010, 17:549-557.
3. Kim H., Farzaneh-Far A. Cardiovascular magnetic resonance in patients with myocardial infarction: current and emerging applications. J Am Coll Cardiol 2010, 55:1-16.
4. Wu H.D., Kwong R.Y. Cardiac magnetic resonance imaging in patients with coronary disease. Curr Treat Options Cardiovasc Med 2008, 10:83-92.
5. Hamon M., Fau G., Née G., et al. Meta-analysis of the diagnostic performance of stress perfusion cardiovascular magnetic resonance for detection of coronary artery disease. J Cardiovasc Magn Reson 2010, 12:29.
6. Caroline. CRD Systematic Reviews.indd, University of York. England, York, York Publishing Services Ltd, Leyerthrope, 2009. pp 1-294.
7. Hombach V., Grebe O., Merkle N., et al. Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005, 26:549.
8. Yan A., Shayne A., Brown K., et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006, 114:32.
9. Kwong R.Y. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006, 113:2733-2743.
10. Roes S., Kelle S., Kaandorp T., et al. Comparison of myocardial infarct size assessed with contrast-enhanced magnetic resonance imaging and left ventricular function and volumes to predict mortality in patients with healed myocardial infarction. Am J Cardiol 2007, 100:930-936.
11. Chalil S., Stegemann B. Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy. Pacing Clin Electrophysiol 2007, 30:1201-1209.
12. Kwong R., Sattar H., Wu H., et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation 2008, 118:1011.
13. Yokota H., Heidary S., Katikireddy C. Quantitative characterization of myocardial infarction by cardiovascular magnetic resonance predicts future cardiovascular events in patients with ischemic cardiomyopathy. J Cardiovasc Magn Reson 2008, 9:17.
14. Wu E., Ortiz J., Tejedor P., et al. Infarct size by contrast enhanced cardiac magnetic resonance is a stronger predictor of outcomes than left ventricular ejection fraction or end-systolic volume index: prospective cohort study. Heart 2008, 94:730.
15. Kim H.W., Klem I., Shah D.J., et al. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients with suspected coronary disease. PLoS Med 2009, 6:e1000057.
16. Kwon D.H., Halley C.M., Carrigan T.P., et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009, 2:34.
17. Roes S.D., Borleffs C.J.W., van der Geest R.J., et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging 2009, 2:183-190.
18. Cochet A., Lorgis L., Lalande A., et al. Major prognostic impact of persistent microvascular obstruction as assessed by contrast-enhanced cardiac magnetic resonance in reperfused acute myocardial infarction. Eur Radiol 2009, 19:2117-2126.
19. Kelle S., Roes S., Klein C., et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009, 54:1770.
20. Steel K., Broderick R., Gandla V., et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation 2009, 120:1390.
21. Bello D., Einhorn A., Kaushal R., et al. Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magn Reson Imaging 2010, 29:50-56.
22. de Waha S., Desch S., Eitel I., et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J 2010, 31(21):2660-2668.
23. Eitel I., Desch S., Fuernau G., et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. JAC 2010, 55:2470-2479.
24. Cochet A., Lalande A., Lorgis L., et al. Prognostic value of microvascular damage determined by cardiac magnetic resonance in non ST-segment elevation myocardial infarction: comparison between first-pass and late gadolinium-enhanced images. Invest Radiol 2010, 45:725-732.
25. Larose E., Rodés-Cabau J., Pibarot P., et al. Predicting late myocardial recovery and outcomes in the early hours of ST-segment elevation myocardial infarction: traditional measures compared with microvascular obstruction, salvaged myocardium, and necrosis characteristics by cardiovascular magnetic resonance. J Am Coll Cardiol 2010, 55:2459-2469.
26. Coelho-Filho O., Mongeon F., Steel K. Combined stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance provides robust prognostic information to cardiac events. J Cardiovas Magn Reson 2011, 13:O2.
27. Krittayaphong R., Saiviroonporn P. Prevalence and prognosis of myocardial scar in patients with known or suspected coronary artery disease and normal wall motion. J Cardiovas Magn Reson 2011, 13:2.
28. Von Elm E., Altman D.G., Egger M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies. Gac Sanit 2008, 22:144-150.
29. Higgins J., Green S. Cochrane handbook for systematic reviews of interventions. England, West Sussex,The Cochrane Collaboration and John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, Cochrane Book Series 2008, Wiley Online Library.
30. Kadish A., Bello D., Finn J., et al. Rationale and design for the defibrillators to reduce risk by magnetic resonance imaging evaluation (DETERMINE) trial. J Cardiovasc Electrophysiol 2009, 20:982-987.
31. Borenstein M.V., Hedges L. Introduction to meta-analysis; (1 edition). Wiley 2009, 421.
32. Kim R.J., Shah D.J., Judd R.M. How we perform delayed enhancement imaging. J Cardiovasc Magn Reson 2003, 5:505-514.
33. Kramer C., Barkhausen J., Flamm S., et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, Society for Cardiovascular Magnetic Resonance: Board of Trustees Task Force on Standardized Protocols. J Cardiovasc Magn Reson 2008, 10:35.
34. Hundley W.G., Bluemke D., Bogaert J.G., et al. Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson 2009, 11:5.
35. Hachamovitch R.D.C.M. Methods and limitations of assessing new noninvasive tests: part II: outcomes-based validation and reliability assessment of noninvasive testing. Circulation 2008, 117:2793-2801.
36. Hachamovitch R.D.C.M. Methods and limitations of assessing new noninvasive tests: part I: anatomy-based validation of noninvasive testing. Circulation 2008, 117:2684-2690.
37. Petersen S., Mohrs O., Horstick G. Influence of contrast agent dose and image acquisition timing on the quantitative determination of nonviable myocardial tissue using delayed contrast-enhanced magnetic resonance imaging. J Cardiovasc Magn Reson 2004, 6:541-548.
38. Sardella G., Mancone M., Bucciarelli-Ducci C., et al. Thrombus aspiration during primary percutaneous coronary intervention improves myocardial reperfusion and reduces infarct size. JAC 2009, 53:309-315.
39. Flett A.S., Hasleton J., Cook C., et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovas Imaging 2011, 4:150-156.
40. Heidary S., Patel H., Chung J., et al. Quantitative tissue characterization of infarct core and border zone in patients with ischemic cardiomyopathy by magnetic resonance is associated with future cardiovascular events. J Am Coll Cardiol 2010, 55:2762-2768.
41. Cheong B., Muthupillai R., Wilson J., et al. Prognostic significance of delayed-enhancement magnetic resonance imaging: survival of 857 patients with and without left ventricular dysfunction. Circulation 2009, 120:2069.